These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25449114)

  • 1. What will be the role of first-trimester ultrasound if cell-free DNA screening for aneuploidy becomes routine?
    Sonek JD; Cuckle HS
    Ultrasound Obstet Gynecol; 2014 Dec; 44(6):621-30. PubMed ID: 25449114
    [No Abstract]   [Full Text] [Related]  

  • 2. First-trimester Ultrasound and Aneuploidy Screening in Multifetal Pregnancies.
    Hirshberg A; Dugoff L
    Clin Obstet Gynecol; 2015 Sep; 58(3):559-73. PubMed ID: 26133496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First trimester contingent testing with either nuchal translucency or cell-free DNA. Cost efficiency and the role of ultrasound dating.
    Conner P; Gustafsson S; Kublickas M
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):368-75. PubMed ID: 25581307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First trimester screening cut-offs for noninvasive prenatal testing as a contingent screen: Balancing detection and screen-positive rates for trisomy 21.
    Maxwell S; James I; Dickinson JE; O'Leary P
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):29-35. PubMed ID: 26749261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.
    Salomon LJ; Alfirevic Z; Audibert F; Kagan KO; Paladini D; Yeo G; Raine-Fenning N;
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):815-816. PubMed ID: 28573775
    [No Abstract]   [Full Text] [Related]  

  • 6. Additional benefits of first trimester screening.
    D'Alton ME; Cleary-Goldman J
    Semin Perinatol; 2005 Dec; 29(6):405-11. PubMed ID: 16533655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies.
    Evans MI; Sonek JD; Hallahan TW; Krantz DA
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):74-83. PubMed ID: 25315699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of ultrasound examination at 10-14 weeks prior to cell-free DNA screening for fetal aneuploidy.
    Vora NL; Robinson S; Hardisty EE; Stamilio DM
    Ultrasound Obstet Gynecol; 2017 Apr; 49(4):465-469. PubMed ID: 27300317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for Down syndrome and congenital abnormalities in the first versus the second trimester].
    Lundsteen C; Brøndum-Nielsen K; Rasmussen K; Petersen GB; Jensen PK
    Ugeskr Laeger; 2000 Mar; 162(11):1580-2. PubMed ID: 10868125
    [No Abstract]   [Full Text] [Related]  

  • 10. First-trimester screening for aneuploidy.
    Brigatti KW; Malone FD
    Obstet Gynecol Clin North Am; 2004 Mar; 31(1):v, 1-20. PubMed ID: 15062444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.
    Benn P; Borell A; Chiu R; Cuckle H; Dugoff L; Faas B; Gross S; Johnson J; Maymon R; Norton M; Odibo A; Schielen P; Spencer K; Huang T; Wright D; Yaron Y
    Prenat Diagn; 2013 Jul; 33(7):622-9. PubMed ID: 23616385
    [No Abstract]   [Full Text] [Related]  

  • 13. Sonography in the first trimester screening of trisomy 21 and other fetal aneuploidies.
    Brambati B; Tului L; Alberti E
    Early Pregnancy; 1996 Sep; 2(3):155-67. PubMed ID: 9363213
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials.
    Perni SC; Predanic M; Kalish RB; Chervenak FA; Chasen ST
    Am J Obstet Gynecol; 2006 Jan; 194(1):127-30. PubMed ID: 16389021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the role of the 11- to 14-week ultrasound in women with negative cell-free DNA screening for aneuploidy?
    Reiff ES; Little SE; Dobson L; Wilkins-Haug L; Bromley B
    Prenat Diagn; 2016 Mar; 36(3):260-5. PubMed ID: 26748490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound screening for fetal abnormalities in the first trimester.
    Chitty LS; Pandya PP
    Prenat Diagn; 1997 Dec; 17(13):1269-81. PubMed ID: 9509545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical perspective of cell-free DNA testing for fetal aneuploidies.
    Gratacós E; Nicolaides K
    Fetal Diagn Ther; 2014; 35(3):151-5. PubMed ID: 24931002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current controversies in prenatal diagnosis 2: are we ready to screen for fetal anomalies with first trimester ultrasound?
    Kontopoulos E; Odibo A; Wilson RD
    Prenat Diagn; 2013 Jan; 33(1):9-12. PubMed ID: 23296714
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for Down's syndrome in the first trimester: combined risk calculation, methodology, and validation of a web-based system.
    Kublickas M; Crossley J; Aitken D
    Acta Obstet Gynecol Scand; 2009; 88(6):635-8, 7p following 638. PubMed ID: 19330568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome.
    Kott B; Dubinsky TJ
    J Am Coll Radiol; 2004 Jun; 1(6):415-21. PubMed ID: 17411619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.